| |
|
|
|
|
|
|
|||
|
Blood, 1 January 2008, Vol. 111, No. 1, pp. 112-121. Prepublished online as a Blood First Edition Paper on September 21, 2007; DOI 10.1182/blood-2006-07-037572.
HEMATOPOIESIS Protein kinase B (c-akt) regulates hematopoietic lineage choice decisions during myelopoiesis1 Molecular Immunology Lab, Department of Immunology, University Medical Center, Utrecht, the Netherlands; 2 Hematopoietic Stem Cell Laboratory, Lund Strategic Research Center for Stem Cell Biology and Cell Therapy, Lund, Sweden; and 3 Department of Pulmonary Diseases, University Medical Center, Utrecht, the Netherlands
Hematopoiesis is a highly regulated process resulting in the formation of all blood lineages. Aberrant regulation of phosphatidylinositol-3-kinase (PI3K) signaling has been observed in hematopoietic malignancies, suggesting that regulated PI3K signaling is critical for regulation of blood cell production. An ex vivo differentiation system was used to investigate the role of PI3K and its downstream effector, protein kinase B (PKB/c-akt) in myelopoiesis. PI3K activity was essential for hematopoietic progenitor survival. High PKB activity was found to promote neutrophil and monocyte development, while, conversely, reduction of PKB activity was required to induce optimal eosinophil differentiation. In addition, transplantation of β2-microglobulin (–/–) NOD/SCID mice with CD34+ cells ectopically expressing constitutively active PKB resulted in enhanced neutrophil and monocyte development, whereas ectopic expression of dominant-negative PKB induced eosinophil development in vivo. Inhibitory phosphorylation of C/EBP
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||||